Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Dual-Imaging Shows Internal Nanoscale Structure, Chemistry of Objects

By LabMedica International staff writers
Posted on 15 Oct 2013
Nanomaterials comprised of particles with dimensions measured in billionths of a meter hold vast potential for creating more effective fuel cells, batteries, catalysts, and drug-delivery systems. More...


Seeing how nanostructured materials inside these devices evolve and interact as they operate is essential to gain clues into ways to optimize performance. However, most studies have looked at idealized samples of isolated components, not as they function in operating devices. A group of researchers at the US Department of Energy’s Brookhaven National Laboratory (Upton, NY, USA) and Columbia University’s (New York, NY, USA) School of Engineering and Applied Science has developed a new kind of “X-ray vision”—a way to peek inside actual devices to map the internal nanostructures and characteristics of the various components, and even track how properties evolve as the devices operate. The innovative dual imaging method described September 30, 2013, in the journal Nature Communications, combines high-intensity X-rays for discerning nanoscale structures with cross-sectional “slices” of the device to target the exact location of the nanostructured components. It creates new opportunities for developments in a wide range of research fields from materials science to biomaterials, geology, environmental science, and health.

“If you think of a battery with an anode, next to a membrane, next to a solid electrolyte, next to another membrane, next to the cathode, and all this wrapped in a steel container, it's pretty opaque from the outside,” said Dr. Simon Billinge, one of the paper’s lead authors and a researcher at both Brookhaven and Columbia Engineering. “What we can do now, with this new dual-imaging method, is look inside the battery and extract the nanostructure from each of those parts of the battery separately, and we can do it without taking the battery apart, and we can also do it while the battery is operating, to follow the chemistry as the materials evolve.”

The X-rays used for this technique are not like the ones used to image a broken bone. They are exquisitely intense, small beams with very high energy produced by a synchrotron light source, a precision scientific instrument located at select research centers around the world, including Brookhaven Lab and the European Synchrotron Radiation Facility (Grenoble, France), where this specific study was conducted. The X-rays generate measurements of the distribution of distances between pairs of atoms in the material, known as atomic pair distribution functions (PDFs), which reveal the nanoscale structure.

Larger scale cross-sectional images of slices of the material taken from multiple angles using computed tomography (CT)--similar to what clinicians use to identify brain injuries after a bad fall--give scientists the spatial data they need to make a three-dimensional (3D) map of the device’s material components and position the information about nanoscale structure on that map.

“Each method is powerful in its own right, but together they give us a whole new kind of picture,” Dr. Billinge said. “For the first time we can separate the nanostructure signals from the different parts of a working device and see what the atoms are doing in each place, without dismantling the object.”

Similar to the imaging methods that have had a huge impact in health care and the physiologic and neurologic sciences, this technique offers unprecedented access to the internal workings of materials at the nanoscale. To demonstrate the technique, the scientists constructed images of a complex phantom sample composed of a mixture of multiple amorphous and semi-crystalline compounds. They were able to tell these distinct phases apart with ease. Then they used the technique to examine the internal structure of a catalyst comprised of palladium nanoparticles on an aluminum oxide support that is widely used in the chemical industry.

“The efficiency of many industrial processes is dependent on the performance of catalysts deposited onto a structural support known as a catalytic body, so it’s extremely pertinent to understand how they are prepared and operate in practice,” Dr. Billinge said.

The technique clearly revealed a non-uniform distribution of particles, with larger particles on the surface and smaller ones on the inside of the material. “It is not clear from this study whether the significant catalytic activity would originate from the larger and more numerous particles located at the periphery, or by the smaller ones in the interior,” Dr. Billinge said. “But by using dynamic PDF-CT to monitor the catalyst as it performs, it is now possible to provide a more complete picture of the catalyst sample and the evolutionary processes by which it develops and operates to understand these relationships, and ultimately to guide improved catalyst design.”

This research was performed while Dr. Billinge was on sabbatical from Columbia and Brookhaven, but will likely continue at the US National Synchrotron Light Source II (NSLS-II) at Brookhaven, when it becomes operational in 2015. “With modern synchrotron light sources, sub-micron X-ray beams are becoming more widely available, allowing for the possibility of PDF-CT imaging with resolution on nanometer length-scales in the near future,” Dr. Billinge said.

Related Links:

Energy’s Brookhaven National Laboratory
Columbia University



Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.